Thalidomide in actinic prurigo.

Area of Science:

• Dermatology
• Pharmacology

Background:

• Actinic prurigo is a severe, chronic photodermatosis causing intense itching and skin lesions.
• Current treatments for actinic prurigo offer limited efficacy and can have significant side effects.

Purpose of the Study:

• To evaluate the efficacy and safety of thalidomide in patients with actinic prurigo.

Main Methods:

• A cohort of fourteen patients diagnosed with actinic prurigo received thalidomide treatment.
• Patient outcomes, including symptom improvement and side effects, were monitored.

Main Results:

• Eleven out of fourteen patients (78.6%) demonstrated sustained clinical improvement with thalidomide.
• Three patients remained symptom-free after cessation of the drug.
• No major adverse events were reported during the study.

Conclusions:

• Thalidomide is a highly effective therapeutic option for managing actinic prurigo.
• The drug's use necessitates strict adherence to contraception measures for women of childbearing potential to mitigate teratogenic risks.